SCHEMBL2472399

SCHEMBL2472399

Fc1ccc(OCCCn2c(=NCc3csc(N4CCN(Cc5ccccc5-c5ccc(Cl)cc5)CC4)n3)[nH]c3ccccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 12/20 0.39
DRD3 P35462 12/20 0.39
HRH3 Q9Y5N1 3/20 0.39
HTR1A P08908 7/20 0.37
HTR2A P28223 7/20 0.37
DRD1 P21728 3/20 0.37
DRD5 P21918 3/20 0.37
HTR7 P34969 2/20 0.37
HRH1 P35367 5/20 0.36
TMEM97 Q5BJF2 3/20 0.36
SIGMAR1 Q99720 3/20 0.36
POLB P06746 1/20 0.35
KCNH2 Q12809 2/20 0.35
SCN9A Q15858 1/20 0.35
HRH2 P25021 2/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD4 P21917 1/20 0.34
ADRA2C P18825 1/20 0.33
ADORA3 P0DMS8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2497608 0.83 TP53 (0.43) DRD2DRD3HRH3HTR1AHTR2A
SCHEMBL2495260 0.79 TP53 (0.45) DRD2DRD3HRH3HTR1AHTR2A
SCHEMBL2478790 0.75 KCNH2 (0.42) DRD2DRD3HTR1AHTR2AHRH1
SCHEMBL2494194 0.70 DRD2 (0.54) DRD2DRD3HRH3HTR1AHTR2A
SCHEMBL2497285 0.68 BCL2L1 (0.41) DRD2DRD3HRH3HTR1AHTR2A
SCHEMBL2491766 0.68 DRD2 (0.47) DRD2DRD3HRH3HTR1AHTR2A
SCHEMBL2495273 0.66 HTR1A (0.51) DRD2DRD3HRH3HTR1AHTR2A
SCHEMBL2494400 0.66 TP53 (0.53) DRD2DRD3HRH3HTR1AHTR2A
SCHEMBL2496525 0.66 TP53 (0.51) DRD2DRD3HRH3HTR1AHTR2A
SCHEMBL2494421 0.65 DRD2 (0.54) DRD2DRD3HRH3HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2373629-A1 COMPOUNDS FOR TREATING CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-12 EP claimed
WO-2010067067-A1 COMPOUNDS FOR TREATING CANCER EVOTEC AG (DE) 2010-06-17 WO claimed
EP-2373629-A1 COMPOUNDS FOR TREATING CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-12 EP disclosed
WO-2010067067-A1 COMPOUNDS FOR TREATING CANCER EVOTEC AG (DE) 2010-06-17 WO disclosed